EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Renal Biomarkers in Heart Failure

Amudha Kumar, Vignesh Chidambaram, Harinivas Shanmugavel Geetha, Marie Gilbert Majella, Mahesh Bavineni, Pramod Kumar Pona, Nishank Jain, Zarina Sharalaya, Subhi J Al'Aref, Aarti Asnani, Emily S Lau, Jawahar L Mehta

JACC: Advances · 2024-02 · 3 (2) · 100765

DOI: 10.1016/j.jacadv.2023.100765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Advances, 2024-02. Verfasst von Amudha Kumar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Loyola University Medical Center, Maywood, Illinois, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule (KIM)-1 are renal biomarkers increasingly appreciated for their role in the risk stratification and prognostication of heart failure (HF) patients. However, very few have been adopted clinically, owing to the lack of consistency.

Objectives

The authors aimed to study the association between cystatin C, NGAL, and KIM-1 and outcomes, mortality, hospitalizations, and worsening renal function (WRF) in patients with acute and chronic HF.

Methods

We included peer-reviewed English-language articles from PubMed and EMBASE published up to December 2021. We analyzed the above associations using random-effects meta-analysis. Publication bias was assessed using funnel plots.

Results

Among 2,631 articles, 100 articles, including 45,428 patients, met the inclusion criteria. Top-tertile of serum cystatin C, when compared to the bottom-tertile, carried a higher pooled hazard ratio (pHR) for mortality (pHR: 1.59, 95% CI: 1.42-1.77) and for the composite outcome of mortality and HF hospitalizations (pHR: 1.49, 95% CI: 1.23-1.75). Top-tertile of serum NGAL had a higher hazard for mortality (pHR: 2.91, 95% CI: 1.49-5.67) and composite outcome (HR: 4.11, 95% CI: 2.69-6.30). Serum and urine NGAL were significantly associated with WRF, with pHRs of 2.40 (95% CI: 1.48-3.90) and 2.01 (95% CI: 1.21-3.35). Urine KIM-1 was significantly associated with WRF (pHR: 1.60, 95% CI: 1.24-2.07) but not with other outcomes. High heterogeneity was noted between studies without an obvious explanation based on meta-regression.

Conclusions

Serum cystatin C and serum NGAL are independent predictors of adverse outcomes in HF. Serum and urine NGAL are important predictors of WRF in HF.

Schlagwörter

Stichwörter der Autor:innen

KIM-1NGALcystatin Ctubular injuryworsening renal function

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Loyola University Medical Center, Maywood, Illinois, USA.
  • Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Department of Internal Medicine, St. Vincent's Hospital, Worcester, Massachusetts, USA.
  • Department of Community Medicine, Sri Venkateshwaraa Medical College Hospital and Research Center, Pondicherry, India.
  • Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Department of Internal Medicine, Louisiana State University, Shreveport, Louisiana, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Kumar, A., Chidambaram, V., Geetha, H. S., Majella, M. G., Bavineni, M., Pona, P. K., Jain, N., Sharalaya, Z., Al'Aref, S. J., Asnani, A., Lau, E. S., & Mehta, J. L. (2024). Renal Biomarkers in Heart Failure. JACC: Advances, 3(2), 100765. https://doi.org/10.1016/j.jacadv.2023.100765

Vancouver

Kumar A, Chidambaram V, Geetha HS, Majella MG, Bavineni M, Pona PK, et al. Renal Biomarkers in Heart Failure. JACC: Advances. 2024;3(2):100765. doi:10.1016/j.jacadv.2023.100765

BibTeX
@article{Kumar2024,
  author = {Kumar, Amudha and Chidambaram, Vignesh and Geetha, Harinivas Shanmugavel and Majella, Marie Gilbert and Bavineni, Mahesh and Pona, Pramod Kumar and Jain, Nishank and Sharalaya, Zarina and Al'Aref, Subhi J and Asnani, Aarti and Lau, Emily S and Mehta, Jawahar L},
  title = {Renal Biomarkers in Heart Failure},
  journal = {JACC: Advances},
  year = {2024},
  volume = {3},
  number = {2},
  pages = {100765},
  doi = {10.1016/j.jacadv.2023.100765}
}
Kostenlos starten →